An ancillary or molecular test is a medical test for a patient that is not a part of the original study design. There are a wide variety of ancillary tests…
Read More
Dr. Matthew O. Leavitt is a Stanford-trained pathologist focused on innovation in digital pathology. He has 19 years of pathology experience. He founded Lumea and then became the founder and…
COVID-19 led to an unexpected rise in the practice of digital pathology. Temporary regulations were put in place to protect pathologists and other healthcare professionals, making diagnosing from a safe…
Would you like to improve accessioning and grossing turnaround time and efficiency while saving your lab money? Lumea technology can help you accomplish this and more without needing to introduce...
Read More
Wyatt Anthony is a pathologists’ assistant, has worked in anatomic pathology for 13 years, and, like many people who have worked in a lab, he hates prostate biopsies. Ever since…
Artificial intelligence and the digital world are invading many job sites worldwide, sometimes displacing jobs and, in other cases, creating new ones. As it infiltrates the world of pathology, some…
